BEAM ▲ +3.8% - Beam Therapeutics Inc.
$BEAM - Beam Therapeutics to Present Updated Clinical Data from BEACON Phase 1/2 Trial of Risto-cel in Sickle Cell Disease in an Oral Presentation at American Society of Hematology (ASH) Annual Meeting
04-NOV-2026 09:00 AM ET
Share this post
More filings for $BEAM
BEAM ▼ -1.6% - Beam Therapeutics Inc.Nov 3, 2026BEAM ▼ -0.5% - Beam Therapeutics Inc.Oct 27, 2026BEAM ▲ +1.3% - Beam Therapeutics Inc.Oct 13, 2026BEAM ▲ +2.7% - Beam Therapeutics Inc.Sep 10, 2026BEAM ▲ +3.7% - Beam Therapeutics Inc.Sep 8, 2026BEAM ▲ +3.5% - Beam Therapeutics Inc.Sep 8, 2026
View full $BEAM filing history →💬 Comments
Loading comments…
Leave a comment